Year | Volume (Price x Shares) | Change |
---|---|---|
2023 | $65.98 M | -70.2% |
2022 | $0.22 B | 107.77% |
2021 | $0.10 B | -72.46% |
2020 | $0.38 B | -11.25% |
2019 | $0.43 B | 203.91% |
2018 | $0.14 B | -20.27% |
2017 | $0.17 B | 4.53% |
2016 | $0.17 B | -7.42% |
2015 | $0.18 B | 76.57% |
2014 | $0.10 B | 237.33% |
2013 | $31.21 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $48.88 M | $0.24 B | ๐บ๐ธ USA |
![]() Novartis NVS | $29.28 M | $71.27 M | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $33.95 M | $0.52 B | ๐บ๐ธ USA |
![]() AbbVie ABBV | $0.15 B | $0.46 B | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $35.38 M | $0.21 B | ๐บ๐ธ USA |
![]() Amgen AMGN | $58.71 M | $0.42 B | ๐บ๐ธ USA |
![]() Sanofi SNY | $7.71 M | $0.11 B | ๐ซ๐ท France |
![]() Biogen BIIB | $6.88 M | $54.41 M | ๐บ๐ธ USA |
![]() Merck MRK | $88.22 M | $0.56 B | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $37.61 M | $0.19 B | ๐ฌ๐ง UK |